CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −2,100 | $183.06 | $384K | 891,463 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −6,644 | $184.20 | $1.2M | 884,819 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −2,951 | $185.04 | $546K | 881,868 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −1,100 | $185.91 | $205K | 880,768 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −100 | $186.75 | $19K | 880,668 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Sale | −200 | $188.75 | $38K | 880,468 |
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −5,208 | 89,782 | ||
| 2021-05-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −9,792 | 97,296 | ||
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −600 | $189.25 | $114K | 427,891 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −1,320 | $190.53 | $252K | 426,571 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −2,880 | $191.83 | $552K | 423,691 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −2,200 | $192.54 | $424K | 421,491 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −300 | $193.84 | $58K | 421,191 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −100 | $194.90 | $19K | 421,091 |
| 2021-05-03 | STUELPNAGEL JOHN R Director | Sale | −100 | $198.09 | $20K | 420,991 |
| 2021-05-03 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 40,357 |
| 2021-05-03 | McAnear Justin J. Chief Financial Officer | Sale | −600 | $189.57 | $114K | 39,757 |
| 2021-05-03 | McAnear Justin J. Chief Financial Officer | Sale | −1,900 | $190.63 | $362K | 37,857 |
| 2021-05-03 | McAnear Justin J. Chief Financial Officer | Sale | −2,700 | $191.77 | $518K | 35,157 |
| 2021-05-03 | McAnear Justin J. Chief Financial Officer | Sale | −3,706 | $192.46 | $713K | 31,451 |
Page 38 of 57 · 1,128 trades